Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice.
INTRODUCTION:Limited data are available on the durability and effectiveness of maraviroc in routine clinical practice. We assessed the durability of maraviroc-containing regimens during a 30-month period, as well as their immunovirological and clinical efficacy, according to viral tropism in treatme...
Main Authors: | Valérie Potard, Jacques Reynes, Tristan Ferry, Céline Aubin, Laurent Finkielsztejn, Yazdan Yazdanpanah, Dominique Costagliola, FHDH ANRS CO4 |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4695083?pdf=render |
Similar Items
-
High Virologic Failure Rates with Maraviroc-Based Salvage Regimens Among Indian Patients: A Preliminary Analysis—Maraviroc Effectiveness in HIV-1 Subtype C
by: Sanjay Pujari MD, et al.
Published: (2018-02-01) -
Clinical use, efficacy, and durability of maraviroc for antiretroviral therapy in routine care: A European survey.
by: Andrea De Luca, et al.
Published: (2019-01-01) -
Impact of etravirine on hospitalization rate between 2005 and 2011 among heavily treated HIV-1-infected individuals on failing regimens
by: Valérie Potard, et al.
Published: (2018-07-01) -
Use of maraviroc, the first CCR5 receptor antagonist, in HIV treatment regimens
by: A V Kravchenko
Published: (2013-11-01) -
Maraviroc in treatment-experienced patients with HIV-1 infection - experience from routine clinical practice
by: Reuter S, et al.
Published: (2010-06-01)